Why the study?
Does preablation history predict postablation atrial fibrillation occurrence in patients undergoing transisthmic ablation for typical atrial flutter?
Does preablation history predict postablation atrial fibrillation occurrence in patients undergoing transisthmic ablation for typical atrial flutter?
Patients with amiodarone-induced atrial flutter have a significantly lower risk of postablation atrial fibrillation compared to those with spontaneous or IC drug-induced flutter.
Answers are grounded in this paper and cite their sources.
Preablation AF history was associated with higher postablation AF risk after flutter ablation; hypothesis-generating for risk-stratified monitoring.
The aim of this prospective study was to compare the long-term follow-up after transisthmic ablation of patients with preablation lone atrial flutter, coexistent AF, and drug induced atrial flutter to determine if postablation AF followed a different clinical course and displayed different predictors in these groups. The study evaluated 357 patients who underwent transisthmic ablation for typical atrial flutter. These were divided into four groups according to their preablation history. Group A included patients with typical atrial flutter and without preablation AF (n=120, 33.6%). Group B included patients with preablation AF and spontaneous atrial flutter (n=132, 37.0%). Group C patients had preablation AF and atrial flutter induced by treatment with IC drugs (propafenone or flecainide) (n=63, 17.6%) Group D included patients with preablation AF and atrial flutter induced by treatment with amiodarone (n=42, 11.8%). During a mean follow-up of 15.2 double dagger 10.6 months (range 6-55 months) AF occurred more frequently in groups B (56.1%) and C (57.1%) patients than in groups A (20.8%, P <0.0001) and D (31.0%, P <0.0001) patients. The results of multivariate analysis revealed that different clinical and echocardiographical variables were correlated with postablation AF occurrence in the different groups. Patients with atrial flutter induced by amiodarone have a significantly lower risk of postablation AF than patients with spontaneous atrial flutter and AF, and those with atrial flutter induced by IC drugs. Different clinical and echocardiographical variables predict postablation AF occurrence in different subgroups of patients.
No takes yet. Share an insight, caveat, or question.
Bertaglia et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: